Table 2 Post-COVID Condition patients characteristics (2022).
No PCC | PCC | p-value | |
|---|---|---|---|
Sex, n (%) | |||
Female | 20 (39.9) | 53 (67.9) | < 0.001 |
Male | 39 (66.1) | 25 (32.1) | |
Age years, median (IQR) | 35.89 (10.69) | 39.61 (15.68) | 0.348 |
Age stratified, n (%) | |||
Up to 40 years | 38 (64.4) | 44 (56.4) | 0.348 |
41–50 | 11 (18.6) | 18 (23.1) | |
51–60 | 6 (10.2) | 11 (14.1) | |
61–70 | 2 (3.4) | 2 (2.6) | |
71–80 | 1 (1.7) | 1 (1.3) | |
Over 81 years | 1 (1.7) | 2 (2.6) | |
Comorbidities at time of COVID-19, n (%) | |||
Hypertension | 15 (25.4) | 24 (30.8) | 0.568 |
Hypercholesterolemia | 4 (6.8) | 11 (14.1) | 0.269 |
Diabetes Mellitus | 5 (8.5) | 13 (16.7) | 0.205 |
Obesity | 17 (28.8) | 25 (32.1) | 0.712 |
Reinfections, (n %) | |||
No | 41 (70.7) | 49 (70.0) | 0.932 |
Yes | 17 (29.3) | 21 (30.0) | |
Infection-related to PCC, n (%) | |||
1 | 43 (74.1) | 74 (94.9) | 0.001 |
2 | 15 (25.9) | 4 (5.1) | |
Hospitalization, n (%) | |||
Yes | 6 (10.2) | 18 (23.1) | 0.049 |
No | 53 (89.9) | 60 (76.9) | |
Severity scale, n (%) | |||
Asymptomatic | 4 (6.8) | 0 | 0.104 |
Mild | 43 (72.9) | 54 (69.2) | |
Moderate | 2 (3.4) | 5 (6.4) | |
Severe | 5 (8.5) | 6 (7.7) | |
Critical | 5 (8.5) | 13 (16.7) | |
